Navellier & Associates’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25,600
| Closed | -$903K | – | 339 |
|
|
2023
Q3 | $903K | Buy |
25,600
+1,485
| +6% | +$52.4K | 0.15% | 144 |
|
|
2023
Q2 | $917K | Buy |
24,115
+1,491
| +7% | +$56.7K | 0.18% | 127 |
|
|
2023
Q1 | $854K | Sell |
22,624
-408
| -2% | -$15.4K | 0.18% | 130 |
|
|
2022
Q4 | $976K | Buy |
+23,032
| New | +$976K | 0.2% | 108 |
|
|
2021
Q2 | – | Sell |
-101,518
| Closed | -$3.33M | – | 320 |
|
|
2021
Q1 | $3.33M | Sell |
101,518
-5,899
| -5% | -$194K | 0.6% | 59 |
|
|
2020
Q4 | $4.37M | Sell |
107,417
-3,203
| -3% | -$130K | 0.79% | 38 |
|
|
2020
Q3 | $4.05M | Buy |
110,620
+256
| +0.2% | +$9.37K | 0.88% | 35 |
|
|
2020
Q2 | $3.74M | Buy |
110,364
+84,340
| +324% | +$2.86M | 0.89% | 33 |
|
|
2020
Q1 | $551K | Sell |
26,024
-2,914
| -10% | -$61.7K | 0.13% | 129 |
|
|
2019
Q4 | $646K | Buy |
+28,938
| New | +$646K | 0.1% | 165 |
|